The ABCG5 ABCG8 sterol transporter and phytosterols: implications for cardiometabolic disease
- PMID: 19306529
- PMCID: PMC4097028
- DOI: 10.1097/med.0b013e3283292312
The ABCG5 ABCG8 sterol transporter and phytosterols: implications for cardiometabolic disease
Abstract
Purpose of review: This review summarizes recent developments in the activity, regulation, and physiology of the ABCG5 ABCG8 (G5G8) transporter and the use of its xenobiotic substrates, phytosterols, as cholesterol lowering agents in the treatment of cardiovascular disease. Recent progress has significant implications for the role of G5G8 and its substrates in complications associated with features of the metabolic syndrome.
Recent findings: Recent reports expand the clinical presentation of sitosterolemia to include platelet and adrenal dysfunction. The G5G8 sterol transporter is critical to hepatobiliary excretion of cholesterol under nonpathological conditions and has been linked to the cholesterol gallstone susceptibility. Finally, the cardiovascular benefits of cholesterol lowering through the use of phytosterol supplements were offset by vascular dysfunction, suggesting that alternative strategies to reduced cholesterol absorption offer greater benefit.
Summary: Insulin resistance elevates G5G8 and increases susceptibility to cholesterol gallstones. However, this transporter is critical for the exclusion of phytosterols from the absorptive pathways in the intestine. Challenging the limits of this protective mechanism through phytosterol supplementation diminishes the cardioprotective benefits of cholesterol lowering in mouse models of cardiovascular disease.
Figures
References
-
- Kidambi S, Patel SB. Sitosterolaemia: pathophysiology, clinical presentation and laboratory diagnosis. J Clin Pathol. 2008;61:588–594. - PubMed
-
- Kidambi S, Patel SB. Cholesterol and noncholesterol sterol transporters: ABCG5, ABCG8 and NPC1L1– a review. Xenobiotica. 2008;38:1119–1139. - PubMed
-
- Kruit JK, Drayer AL, Bloks VW, et al. Plant sterols cause macrothrombocytopenia in a mouse model of sitosterolemia. J Biol Chem. 2008;283:6281–6287. This study provides a mechanism for platelet dysfunction sitosterolemia. - PubMed
-
- Mushtaq T, Wales JK, Wright NP. Adrenal insufficiency in phytosterolaemia. Eur J Endocrinol. 2007;157(Suppl 1):S61–S65. - PubMed
-
- Tang W, Ma Y, Jia L, et al. Genetic inactivation of NPC1L1 protects against sitosterolemia in mice lacking ABCG5/ABCG8. J Lipid Res. 2009;50:293–300. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
